VEEV · Veeva Systems Inc

Track VEEV — free

$273.33 -8.60 (-3.05%) At close · Oct 2

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$45.44B

161.91M

Volume · Oct 2 1.08M Avg daily vol (3M) 1.71M

Up next

Next earnings call

Nov 22, 2026 Est · unconfirmed · in 7 wks

Latest filing: 10-Q

filed Aug 27, 2026

Q2 2027 earnings call transcript

call held Aug 26, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$3.46B

Trailing 12 months

Net income (TTM)

$1.01B

Trailing 12 months

Revenue growth YoY

+17.6%

Year over year

Operating margin

29.9%

Trailing 12 months

P / E (TTM)

44.7

Trailing earnings · reciprocal yield 2.2%

FCF yield

—

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

$1.81B

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

-1.6%

Year over year · fewer shares

Price change (1Y)

-9.1%

Trailing year

Short interest

3.1%

Latest settlement · 4.0 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Neutral Momentum Strong Sentiment Neutral Fundamentals Excellent Quant / Vol High

Market backdrop VIX 15.3 · calm Equity put/call 0.58

Technical

price trend

Neutral

50 / 200-day cross No cross

Price vs 200-day avg +36%

above

Price vs 50-day avg +9%

above

RSI (14) 56

neutral

MACD trend Negative

52-week position 79%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Strong

1-month return −4%

trailing

6-month return +73%

trailing

YTD return +22%

this year

Relative strength +60%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $251 › 200d $201 — 50d above 200d

Institutional flow Accumulating

5 of 1,076 funds reported for Sep 30 · net +1.3K sh shares · +1 new

Insider flow Distributing

Net -$195.8K over 90 days · 100% sells

Short interest Rising

3.07% of float · ▲ +2.9% MoM · 4.0 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

1,076 holders — mid 3-yr range

Squeeze score 65

elevated · 0–100

Fundamentals

Excellent

Revenue growth +28%

Y/Y

Gross margin 219%

contracting

EPS growth +26%

Y/Y

Free cash flow $1.4B

Valuation P/E 45.9

rich

Buyback $1.4B

remaining

Quant / Vol

risk profile

High

Volatility 43%

annualized · 1-yr

Max drawdown −51%

past year

ATR 3.4%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Beat or met 7 of last 8

Latest guidance · from the 8-K filed Aug 26, 2026

fiscal third quarter ending October 31, 2026

Total revenues $932M – $935M

prior qtr $927.96M midpoint +0.6% QoQ

Non-GAAP operating income Non-GAAP $417M – $420M

Non-GAAP fully diluted net income per share Non-GAAP $2.33 – $2.34

fiscal year ending January 31, 2027

Total revenues Initiated $3.68B – $3.69B

prior FY $3.2B midpoint +15.3% Y/Y

Non-GAAP operating income Non-GAAP Initiated $1.64B

Non-GAAP fully diluted net income per share Non-GAAP Initiated $9.21

Guided vs delivered · last 8 settled

Total revenues fiscal second quarter ending July 31, 2024

guided $666M – $669M

guided $666M – $669M $676.18M Beat +1.3%

Total revenues fiscal year ending January 31, 2025

guided $2.7B – $2.71B

guided $2.7B – $2.71B $2.75B Beat +1.5%

Total revenues fiscal first quarter ending April 30, 2024

guided $640M – $643M

guided $640M – $643M $650.35M Beat +1.4%

Total revenues fiscal third quarter ending October 31, 2023

guided $614M – $616M

guided $614M – $616M $616.51M Beat +0.2%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral

1 · 4 · 2

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+36% Bullish

Price vs 50-day avg

+9% Bullish

RSI (14)

56 Neutral

MACD trend

Negative Bearish

52-week position

79% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bearish · 2 of 6

Trend (MA cross) No cross

50d $251 › 200d $201 — 50d above 200d

Institutional flow Accumulating

5 of 1,076 funds reported for Sep 30 · net +1.3K sh shares · +1 new

Insider flow Distributing

Net -$195.8K over 90 days · 100% sells

Short interest Rising

3.07% of float · ▲ +2.9% MoM · 4.0 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

1,076 holders — mid 3-yr range

Price context

position in its 52-week range

Range low $151 Now $273 · 79% Range high $306

vs 200-day avg +36% vs 50-day avg +9%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Diluted net income per share on a non-GAAP basis non-GAAP	$2.35	Three months ended July 31, 2026 filing	—
GAAP → non-GAAP reconciliation GAAP Diluted net income per share on a GAAP basis $1.66 +$0.83 Stock-based compensation expense +$0.02 Amortization of purchased intangibles +$0 Litigation settlement-related charges -$0.16 Income tax effect on non-GAAP adjustments = Diluted net income per share on a non-GAAP basis $2.35
Net cash provided by operating activities on a non-GAAP basis non-GAAP	235.44M	Three months ended July 31, 2026 filing	—
GAAP → non-GAAP reconciliation GAAP Net cash provided by operating activities on a GAAP basis 238.71M -3.27M Excess tax (benefit) deficiency from employee stock plans = Net cash provided by operating activities on a non-GAAP basis 235.44M
Net income on a non-GAAP basis non-GAAP	387.41M	Three months ended July 31, 2026 filing	—
GAAP → non-GAAP reconciliation GAAP Net income on a GAAP basis 273.43M +136.8M Stock-based compensation expense +4.06M Amortization of purchased intangibles +0K Litigation settlement-related charges -26.88M Income tax effect on non-GAAP adjustments = Net income on a non-GAAP basis 387.41M
Operating income on a non-GAAP basis non-GAAP	415.88M	Three months ended July 31, 2026 filing	—
GAAP → non-GAAP reconciliation GAAP Operating income on a GAAP basis 275.02M +136.8M Stock-based compensation expense +4.06M Amortization of purchased intangibles +0K Litigation settlement-related charges = Operating income on a non-GAAP basis 415.88M

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Health Information Services — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
VEEV Veeva Systems Inc this stock	$45.44B	+22.4%	+28.1%	45.9	3.1%
TEM Tempus AI, Inc.	$15.34B	+29.8%	+83.4%	—	15.6%
PMDIY Pro Medicus Ltd./ADR	$12.20B	-29.7%	—	—	0.0%
BTSG BrightSpring Health Services, Inc.	$11.02B	+60.9%	+28.2%	33.8	5.1%
HNGE Hinge Health, Inc.	$7.71B	+110.3%	+50.6%	71.8	6.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

1,077

% held: 90.9%
Reported: 5 of 1,076
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

848

View

Short & Settlement

Short Interest Rising

Shares short

5.0M

Days to cover: 4.0d
Change: +140.1K sh

View

Short Volume

Short vol %

51%

As of: Oct 2, 2026

Short Total

View

Fails to Deliver

FTD shares

20.0K

Value: $5.5M
As of: Sep 8, 2026

View

Off-Exchange

Off-exchange %

59.1%

Week of: Aug 24, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$195.8K

Buyers / Sellers: 0 / 1

Buyers Sellers

View

Congressional Trades Buy

Member

Rob Bresnahan

Amount: $1.0K–$15.0K
Traded: May 29, 2025

View

Financials

Revenue (FY)

$3.2B

Net income (FY): $908.9M
EPS diluted: $5.44

View

Buybacks

Authorized

$2.0B

Remaining: $1.4B

Spent Remaining

View

Filings

SEC Filings

Latest

Investor Event Transcript

Filed: Sep 9, 2026
This year: 12

View

Proposed Sales

Value

$1.3M

Shares: 4.8K
Filed: Oct 2, 2026

View

Earnings & Events

Webcasts

Last webcast

Sep 9, 2026

View

Investor Relations

Performance

	5D	20D	120D	MTD	YTD
VEEV	-2.6%	-3.9%	+72.5%	-4.3%	+22.4%
SPY	-0.2%	-0.5%	+12.2%	+0.9%	+12.9%
vs SPY	-2.4%	-3.4%	+60.3%	-5.2%	+9.6%

Capital returns

Buyback program · as of Jul 31, 2026

Authorized

$2.00B

Spent (derived)

$600.00M

Remaining

$1.40B

Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1393052 CUSIP 922475108 13F (30d) 23 filings 19 filers Visit website Investor relations

VEEV · Veeva Systems Inc

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns